Document:

Secured Promissory Note, dated Nov. 1, 2002

 EXHIBIT 10.3 
  
 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS NOTE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS NOTE UNDER SAID
ACT OR AN OPINION OF COUNSEL SATISFACTORY TO COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED. 
  
 SAGENT TECHNOLOGY,
INC. 
  
 SECURED PROMISSORY NOTE 
  
 US$5,000,000.00 
 November 1, 2002 
 Mountain View, California 
  
 FOR VALUE RECEIVED Sagent Technology, Inc., a Delaware corporation
(“Company”) promises to pay to CDC Software Corporation, a Cayman Islands corporation (“Investor”), or its registered assigns, in lawful money of the United States of America the principal sum of Five Million
Dollars ($5,000,000.00), or such lesser amount as shall equal the outstanding principal amount hereof, together with interest from the date of this Note on the unpaid principal balance at a rate equal to 12 percent (12.00%) per annum, computed on
the basis of the actual number of days elapsed and a year of 365 days. All unpaid principal, together with any then unpaid and accrued interest and other amounts payable hereunder, shall be due and payable on the earlier of (i) October 31, 2004 (the
“Maturity Date”), or (ii) when, upon or after the occurrence of a Change of Control (as defined below) or an Event of Default (as defined below), such amounts are declared due and payable by Investor or made automatically due and
payable in accordance with the terms hereof. This Note is one of the “Notes” issued pursuant to that certain Note and Warrant Purchase Agreement dated October 24, 2002 (as amended, modified or supplemented, the “Note Purchase
Agreement”) by and between Company and Investor. Capitalized terms used but not otherwise defined herein shall have the meaning ascribed thereto in the Note Purchase Agreement. 
  
 THE OBLIGATIONS DUE UNDER THIS NOTE ARE SECURED BY A SECURITY AGREEMENT DATED OCTOBER 24, 2002 (THE “SECURITY AGREEMENT”) AND A PLEDGE AGREEMENT DATED NOVEMBER 1,
2002 (THE “PLEDGE AGREEMENT”), EACH OF WHICH IS EXECUTED BY COMPANY FOR THE BENEFIT OF INVESTOR. ADDITIONAL RIGHTS OF INVESTOR ARE SET FORTH IN THE SECURITY AGREEMENT. 
  
 The following is a statement of the rights of Investor and the conditions to which this Note is subject, and to which Investor, by the acceptance of this Note, agrees:

  
 1. Definitions. As used in this Note, the following capitalized terms have the following meanings:

  
 (a) “Act” shall mean the Securities Act of 1933, as amended.

  
 (b) “Collateral” has the meaning given to it in the Security Agreement. 
  
 (c) “Change of Control” shall mean (i) any consolidation or merger involving Company pursuant to which Company’s
stockholders own less than fifty percent (50%) of the voting securities of the surviving entity or (ii) the sale of all or substantially all of the assets of Company. 
  
 (d) “Company” includes the corporation initially executing this Note and any Person which shall succeed to or assume the obligations of Company under this
Note. 
  
 (e) “Event of Default” has the meaning given to it in Section 7 hereof. 

 
 (f) “GAAP” shall mean generally accepted accounting principles as applied in the United States. 

 
 (g) “Investor” shall mean the Person specified in the introductory paragraph of this Note or any Person who
shall at the time be the registered Investor of this Note. 
  
 (h) “Investor Expenses” shall mean
all reasonable cost and expenses (including reasonable attorney fee and expenses) incurred in connection with the preparation, negotiation and enforcement of the Transaction Documents, and Investor’s reasonable attorneys fees and expenses
incurred in amending, enforcing or defending the Transaction Documents during and after an Event of Default (as set forth in Section 5 hereof) whether or not a suit is brought. 
  
 (i) “Investor’s Rights Agreement” has the meaning given to it in the Note Purchase Agreement. 
  

(j) “Lien” has the meaning given to it in the Note Purchase Agreement. 
  
 (k) “Note Purchase Agreement” has the meaning given to it in the introductory paragraph hereof. 
  
 (l) “Obligations” shall mean and include all loans, advances, debts, liabilities and obligations, howsoever arising, owed by Company to Investor of every
kind and description (whether or not evidenced by any note or instrument and whether or not for the payment of money), now existing or hereafter arising under or pursuant to the terms of this Note or any of the other Transaction Documents,
including, all interest, fees, charges, expenses, attorneys’ fees and costs and accountants’ fees and costs chargeable to and payable by Company hereunder and thereunder, in each case, whether direct or indirect, absolute or contingent,
due or to become due, and whether or not arising after the commencement of a proceeding under Title 11 of the United States Code (11 U. S. C. Section 101 etseq.), as amended from time to time (including post-petition interest) and whether or not
allowed or allowable as a claim in any such proceeding. 
  
 (m) “Permitted Liens” has the meaning
given to it in the Note Purchase Agreement. 

 
 2 

  
 (n) “Person” shall mean and include an individual, a
partnership, a corporation (including a business trust), a joint stock company, a limited liability company, an unincorporated association, a joint venture or other entity or a governmental authority. 
  
 (o) “Pledge Agreement” has the meaning given to it in the second paragraph hereof. 
  
 (p) “Security Agreement” has the meaning given to it in the second paragraph hereof. 
  
 (q) “Transaction Documents” shall mean this Note, each of the other Notes issued under the Note Purchase Agreement, the
Note Purchase Agreement, the Warrants issued under the Note Purchase Agreement, Investor’s Rights Agreement, the Security Agreement, the Blocked Account Agreement and the Pledge Agreement together with any other document or agreement executed
and delivered in connection herewith or therewith. 
  
 (r) “Material Adverse Effect” has the meaning
given to it in the Note Purchase Agreement. 
  
 2. Interest. 
  
 (a) Interest Rate. Accrued interest on this Note shall be payable on the last business day of each calendar quarter until the
outstanding principal amount hereof shall be paid in full at maturity, with the first such payment due on December 31, 2002. 
  
 (b) Default Rate. All unpaid principal, together with any unpaid and accrued interest and other amounts payable hereunder shall bear interest, from and after the occurrence and during the continuance of an Event of Default, at
a rate equal to two and one-half percentage points (2 1⁄2%) above the interest rate applicable immediately prior to the occurrence of such Event of Default or the maximum rate permissible by law, whichever is less. 
  
 3. Prepayment. In the event that Company reports a net income for the six month period ended June 30, 2003 (excluding any non-cash
charges associated with the warrants issued pursuant to the Note Purchase Agreement) in its financial statements included in its quarterly report on Form 10-Q for the fiscal quarter ended June 30, 2003, Company may at anytime thereafter, upon five
(5) days prior written notice to Investor, prepay this Note in whole; provided, however, that: (i) the outstanding principal of this Note for purposes of such prepayment shall be determined by multiplying the actual outstanding principal as of the
date of the written notice by 120% (the “Deemed Outstanding Principal”) and (ii) any such prepayment will be applied first to the payment of expenses due under this Note and the other Transaction Documents, second to interest
accrued on this Note and third, if the amount of prepayment exceeds the amount of all such expenses and accrued interest, to the payment of the Deemed Outstanding Principal. 
  
 4. Change of Control. Upon a Change of Control, all unpaid principal, together with any then unpaid and accrued interest and other amounts payable hereunder shall
become immediately due and payable. 

 
 3 

 5. Affirmative Covenants. Until such time as all unpaid principal, together with any unpaid and accrued interest
and other amounts payable hereunder have been indefeasibly paid in full, Company shall: 
 (a) Conduct of Business and Maintenance of Existence and
Assets. (i) Conduct continuously and operate actively its business according to good business practices and maintain all of its properties useful or necessary in its business in good working order and condition (reasonable wear and tear excepted
and except as may be disposed of in accordance with the terms of this Note), including, without limitation, all intellectual property of Company and take all actions necessary to enforce and protect the validity of any such intellectual property;
(ii) keep in full force and effect its existence and comply in all material respects with the laws, rules and regulations governing the conduct of its business where the failure to do so could reasonably be expected to have a Material Adverse
Effect; and (iii) make all such reports and pay all such franchise and other taxes and license fees and do all such other acts and things as may be lawfully required to maintain its rights, licenses, leases, powers and franchises under the laws of
the United States or any political subdivision thereof where the failure to do so could reasonably be expected to have a Material Adverse Effect on Company; 
 (b) Violations. Promptly notify Investor in writing of any violation of any law, statute, rule, regulation, or ordinance of any governmental body, or of any agency thereof, applicable to Company which could reasonably be
expected to have a Material Adverse Effect; 
 (c) Taxes. Make, and cause each Subsidiary to make, due and timely payment or deposit of all material
federal, state, and local taxes, assessments, or contributions required of it by law, and will execute and deliver to the Investor, promptly following the Investor’s request therefore, appropriate certificates attesting to the payment thereof;
and 
 (d) Operational Agreements. Company and Investor agree to negotiate in good faith towards the execution of operational agreements between
Company and Investor with respect to Company’s business. The nature of such agreements may include any of an OEM agreement, master distributor agreement with most favored nation status, transfer of assets by Company to CDC, joint venture or
other transaction. Company and Investor also agree to negotiate in faith an agreement whereby Company will provide Investor with the right of refusal with respect to any of its future outsourcing of research and development operations and any
related training. 
 6. Negative Covenants. Until such time as all unpaid principal, together with any unpaid and accrued interest and other amounts
payable hereunder have been paid in full, Company shall not: 
  
 (a) Indebtedness. Incur any Indebtedness,
except (i) to Investor, (ii) in connection with capital lease arrangements incurred in the ordinary course of business, or (iii) other Indebtedness incurred in the ordinary course of business in an aggregate outstanding principal amount not in
excess of US$500,000 at any time; 
  
 (b) Loans. Make advances, loans or extensions of credit to any Person,
including without limitation, any Subsidiary or Affiliate; 

 
 4 

  
 (c) Guarantees. Become liable upon the obligations or liabilities of any
Person by assumption, endorsement or guaranty thereof or otherwise, except the endorsement of checks in the ordinary course of business or guaranties of Indebtedness of a Subsidiary permitted by Section 6(a)(ii) or 6(a)(iii); 

 
 (d) Dividends. Pay any dividends or make any other distribution or payment on account of or in redemption, retirement or
purchase of any capital stock, or permit any of its Subsidiaries to do so, except that (i) Company may repurchase the stock of former employees pursuant to stock repurchase agreements as long as an Event of Default does not exist prior to such
repurchase or would not exist after giving effect to such repurchase or (ii) any Subsidiary may make dividends or distributions to Company; 
  
 (e) Nature of Business. Substantially change the nature of the business in which it is presently engaged, nor purchase or invest, directly or indirectly, in any assets or property other than in
the ordinary course of business for assets or property which are useful in, necessary for and are to be used in its business as presently conducted; 
  
 (f) Transactions with Affiliates. Directly or indirectly, purchase, acquire or lease any property from, or sell, transfer or lease any property to, or otherwise enter into any transaction or
deal with, any Affiliate other than in the ordinary course of business, on an arm’s-length basis on terms and conditions no less favorable than terms and conditions which would have been obtainable from a Person other than an Affiliate;

  
 (g) Acquisitions. Acquire all or a substantial portion of the assets or voting securities of any Person
(or of any Subsidiary, division or operating unit of any Person); 
  
 (h) Partnerships. Enter into any
partnership, joint venture or similar arrangement whereby Company is obligated to make any payments or other contributions in connection with such arrangements in excess of US$500,000, individually or in the aggregate; 
  
 (i) Retention Payments. Without prior approval by Company’s board of directors or compensation committee thereof, make any
retention or bonus payment to any individual in an amount in excess of $250,000; or 
  
 (j) Transfers to
Subsidiaries. Transfer to Foreign Subsidiaries cash or other assets in an aggregate Net Amount outstanding on any date in excess of 20% of the Company’s market capitalization as of the close of the preceding business day; provided, that (i)
such transfers shall be made in the ordinary course of business, (ii) a reduction in Company’s market capitalization after making any transfers that were permitted by this Section 6(j) shall not render such transfers in violation of this
Section 6(j); and (iii) that in the event Company requests a waiver of this covenant, Investor shall not unreasonably withhold its consent thereto. As used in this Section 6(j), (1) “Foreign Subsidiary” shall mean any Subsidiary of Company
that was not incorporated or organized in the United States, and (2) “Net Amounts” shall mean the aggregate outstanding amount of all transfers of cash or other assets to Foreign Subsidiaries, giving effect to (x) any previous or
concurrent transfers of cash or other assets to Company from Foreign Subsidiaries and (y) any amounts previously or concurrently collected by Company in respect of accounts receivable that were invoiced directly by Company as a result of sales by
Foreign Subsidiaries. 
  

 
 5 

  
 7. Events of Default. The occurrence of any of the following shall
constitute an “Event of Default” under this Note: 
  
 (a) Failure to Pay. Company shall fail to pay
(i) when due any principal or interest payment on the due date hereunder or (ii) any other payment required under the terms of this Note or any other Transaction Documents on the date due and such payment shall not have been made within three (3)
business days of Company’s receipt of Investor’s written notice to Company of such failure to pay; 
  
 (b)
Voluntary Bankruptcy or Insolvency Proceedings. Company shall (i) apply for or consent to the appointment of a receiver, trustee, liquidator or custodian of itself or of all or a substantial part of its property, (ii) be unable, or admit in
writing its inability, to pay its debts generally as they mature, (iii) make a general assignment for the benefit of its or any of its creditors, (iv) be dissolved or liquidated, (v) become insolvent (as such term may be defined or interpreted under
any applicable statute), (vi) commence a voluntary case or other proceeding seeking liquidation, reorganization or other relief with respect to itself or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or
consent to any such relief or to the appointment of or taking possession of its property by any official in an involuntary case or other proceeding commenced against it, or (vii) take any action for the purpose of effecting any of the foregoing;

  
 (c) Involuntary Bankruptcy or Insolvency Proceedings. Proceedings for the appointment of a receiver,
trustee, liquidator or custodian of Company or of all or a substantial part of the property thereof, or an involuntary case or other proceedings seeking liquidation, reorganization or other relief with respect to Company or the debts thereof under
any bankruptcy, insolvency or other similar law now or hereafter in effect shall be commenced and an order for relief entered or such proceeding shall not be dismissed or discharged within thirty (30) days of commencement; 
  
 (d) Insolvency. Company shall admit in writing its inability to pay its debts as they come due or cease operations of its present
business; 
  
 (e) Judgments. Any judgment or judgments are rendered or judgment liens filed against Company
for an aggregate amount in excess of US$500,000, not otherwise covered by insurance, which within forty-five (45) days of such rendering or filing is neither fully satisfied, stayed nor discharged of record; except that this Section 7(e) shall not
apply to any matters related to or arising out of matters listed under section 3(i) of the Company Disclosure Letter; 
  
 (f) Representations and Warranties. Any representation or warranty made by Company in this Agreement, any Transaction Document or in any certificate, furnished at any time in connection herewith or therewith shall not have
been true and correct in all material respects when made; 
  
 (g) Covenants. Company shall be in breach of any
covenant made hereunder or in any Transaction Document and such breach shall remain uncured for thirty (30) consecutive days. 

 
 6 

  
 (h) Liens. Any Lien in favor of Investor created under the Security
Agreement, the Pledge Agreement or the Blocked Account Agreement with respect to any material portion of the Collateral for any reason ceases to be or is not a valid and perfected Lien; 
  
 (i) Seizure. Any material portion of the Collateral shall be seized or taken by a governmental body, or Company or the title and rights of Company or any original
owner which is the owner of any material portion of the Collateral shall have become the subject matter of claim, litigation, suit or other proceeding which could, in the opinion of Investor, upon final determination, result in impairment or loss of
the security provided by this Agreement or the Transaction Documents, and such action shall not have been stayed or dismissed within forty-five (45) days; 
  
 (j) Key Employee. Andre Boisvert or Steven Springsteel shall cease to be employed by the Company for any reason whatsoever and a suitable replacement to the Investors reasonable satisfaction
shall not have assumed such their respective positions within a period of one-hundred twenty (120) days after such position has first become vacated; or 
  
 (k) Value of Collateral. Company shall have acknowledged in writing with the Securities and Exchange Commission that the value of a material portion of its Intellectual Property has suffered a
material diminution in value. In no event shall any reduction solely in Company’s goodwill be deemed a default under this Section 7(k). 
  
 (l) Defaults. A default shall have occurred under any other Indebtedness in an outstanding principal amount of $200,000 or more, which default permits the holder thereof to accelerate the
maturity of such Indebtedness. 
  
 8. Rights of Investor upon Default. Upon the occurrence or existence of any
Event of Default (other than an Event of Default, referred to in Sections 7(b) and 7(c)) and at any time thereafter during the continuance of such Event of Default, Investor may, by written notice to Company, declare all outstanding Obligations
payable by Company hereunder to be immediately due and payable without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived. Upon the occurrence or existence of any Event of Default described in
Sections 7(b) and 7(c), immediately and without notice, all outstanding Obligations payable by Company hereunder shall automatically become immediately due and payable, without presentment, demand, protest or any other notice of any kind, all of
which are hereby expressly waived. In addition to the foregoing remedies, upon the occurrence or existence of any Event of Default, Investor may exercise any other right power or remedy or otherwise permitted to it by law, either by suit in equity
or by action at law, or both. 
  
 9. Expenses. Company shall reimburse and indemnify Investor for Investor
Expenses which shall include, without limitation, reasonable attorneys’ fees (including the allocated costs of in house counsel) and disbursements incurred by Investor (a) in all efforts made to enforce payment of any Obligation or effect
collection of any Collateral or (b) in instituting, maintaining, preserving, enforcing and foreclosing on Investor’s security interest in or Lien on any of the Collateral or maintaining, preserving or enforcing any of Investor’s rights
hereunder, in any case, whether through judicial proceedings or otherwise. 

 
 7 

  
 10. Indemnity. Company shall indemnify Investor and its officers,
directors, Affiliates, attorneys, employees and agents (each, a “Indemnified Party”) from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses and disbursements of
any kind or nature whatsoever (including, without limitation, fees and disbursements of counsel) which may be imposed on, incurred by, or asserted against Indemnified Party in any claim, litigation, proceeding or investigation instituted or
conducted by any governmental agency or instrumentality or any other Person (other than another Indemnified Party or Company) relating to or arising out of this Note or any other Transaction Document, whether or not Indemnified Party is a party
thereto, except to the extent that any of the foregoing arises out of the negligence, gross negligence or misconduct of the Indemnified Party. 
  
 11. Successors and Assigns. Subject to the restrictions on transfer described in Sections 13 and 14 below, the rights and obligations of Company and Investor of this Note shall be binding upon
and benefit the successors, assigns, heirs, administrators and transferees of the parties. 
  
 12. Entire
Agreement. This Note together with the other Transaction Documents constitute and contain the entire agreement among Company and Investor and supersede any and all prior agreements, negotiations, correspondence, understandings and communications
among the parties, whether written or oral, respecting the subject matter hereof. 
  
 13. Waiver and
Amendment. Any provision of this Note may be amended, waived or modified upon the written consent of Company and Investor. Investor hereby agrees that, upon the request from Company for any waiver or amendment hereunder, Investor will promptly
forward such request to the Executive Committee of Investor’s ultimate parent company, chinadotcom corporation, and will use reasonable efforts to respond to such request within two (2) weeks from the date of such request. 

 
 14. Transfer of this Note. With respect to any offer, sale or other disposition of this Note, Investor will give written
notice to Company prior thereto, describing briefly the manner thereof, together with a written opinion of Investor’s counsel, or other evidence if reasonably satisfactory to Company, to the effect that such offer, sale or other distribution
may be effected without registration or qualification (under any federal or state law then in effect). Upon receiving such written notice and reasonably satisfactory opinion, if so requested, or other evidence, Company, as promptly as practicable,
shall notify Investor that Investor may sell or otherwise dispose of this Note, all in accordance with the terms of the notice delivered to Company. If a determination has been made pursuant to this Section 14 that the opinion of counsel for
Investor, or other evidence, is not reasonably satisfactory to Company, Company shall so notify Investor promptly after such determination has been made. Each Note thus transferred and each certificate representing the securities thus transferred
shall bear a legend as to the applicable restrictions on transferability in order to ensure compliance with the Securities Act, unless in the opinion of counsel for Company such legend is not required in order to ensure compliance with the
Securities Act. Company may issue stop transfer instructions to its transfer agent in connection with such restrictions. Subject to the foregoing, transfers of this Note shall be registered upon registration books maintained for such purpose by or
on behalf of Company. Prior to presentation of this Note for registration of transfer, Company shall treat the registered Investor hereof as the owner and Investor of this Note for the purpose of receiving all payments of principal and interest
hereon and for all other purposes 

 
 8 

  
 whatsoever, whether or not this Note shall be overdue and Company shall not be affected by notice to the
contrary. 
  
 15. Assignment by Company. Neither this Note nor any of the rights, interests or obligations
hereunder may be assigned, by operation of law or otherwise, in whole or in part, by Company without the prior written consent of Investor. 
  
 16. Notices. All notices, requests, demands, consents, instructions or other communications required or permitted hereunder shall be in writing and faxed or delivered by courier to each party at
the respective addresses of the parties as set forth in the Note Purchase Agreement, or at such other address or facsimile number as Company shall have furnished to Investor in writing. All such notices and communications shall be effective (a) when
sent by Federal Express or other overnight service of recognized standing, on the second business day following the deposit with such service; and (b) when faxed, upon confirmation of receipt. 
  

17. Usury. In the event any interest is paid on this Note that is deemed to be in excess of the then legal maximum rate, then that portion of the interest
payment representing an amount in excess of the then legal maximum rate shall be deemed a payment of principal and applied against the principal of this Note. 
  
 18. Waivers. Company hereby waives notice of default, presentment or demand for payment, protest or notice of nonpayment or dishonor and all other notices or demands relative to this instrument.

  
 19. Governing Law. This Note and all actions arising out of or in connection with this Note shall be
governed by and construed in accordance with the laws of the State of California, without regard to the conflicts of law provisions of the State of California, or of any other jurisdiction. EACH OF INVESTOR AND COMPANY, TO THE FULLEST EXTENT
PERMITTED BY APPLICABLE LAW, HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY AS TO ANY ISSUE RELATING HERETO IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS NOTE. 
  
 [Remainder of page intentionally left blank.] 
  

 
 9 

  
 IN WITNESS WHEREOF, Company has caused this Note to be issued as of the
date first written above. 
  
 
	 SAGENT TECHNOLOGY, INC.
 a Delaware corporation
 
	 
	 By:
 	 	 

	  	 	  
	 Name:
 	 	 

	  	 	  
	 Title:
 	 	 

 
  
  
 Acknowledged and Accepted: 

 
 
	 CDC SOFTWARE CORPORATION
 a Cayman Islands corporation

	 
	 By:
 	 	 

	  	 	  
	 Name:
 	 	 

	  	 	  
	 Title:
 	 	 

 
  
 [Signature page to Secured Promissory Note]Warrant, dated Nov. 1, 2002

 EXHIBIT 10.4 
  
 THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED
EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR AN OPINION OF COUNSEL OR OTHER EVIDENCE SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED. THIS WARRANT MUST BE SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS
A CONDITION PRECEDENT TO THE SALE, PLEDGE OR OTHER TRANSFER OF ANY INEREST IN ANY OF THE SHARES REPRESENTED BY THIS WARRANT. 
  
 SAGENT TECHNOLOGY, INC. 
  
 WARRANT TO PURCHASE SHARES 
  
 Warrant No.:  W-6 
 November 1, 2002

  
 Mountain View, California 
  
 THIS WARRANT is issued to CDC Software Corporation by Sagent Technology, Inc., a Delaware corporation (the “Company”), pursuant to the terms of that certain Note and Warrant Purchase
Agreement dated October 24, 2002 by and between the Company and CDC Software Corporation (the “Note Purchase Agreement”). 
  
 1. Purchase of Shares. Subject to the terms and conditions hereinafter set forth, the holder of this Warrant is entitled, upon surrender of this Warrant at the principal executive offices of the Company (or at such
other place as the Company shall notify the holder hereof in writing), to purchase from the Company up to 5,714,285 fully paid and nonassessable Shares (as defined below). 
  
 2. Definitions. 
  
 (a)
Exercise Price. The exercise price for the Shares shall be US$0.10 per share (as adjusted from time to time pursuant to Section 6 hereof). 
  
 (b) Exercise Period. This Warrant shall be exercisable, in whole or in part, during the term commencing on the date hereof and ending on the expiration of this Warrant pursuant to Section 15
hereof. 
  
 (c) Shares. The term “Shares” shall mean shares of the Company’s common
stock, par value US$0.001 per share (“Common Stock”). 
  
 (d) Change of Control. The term
“Change of Control” shall mean (i) any consolidation or merger involving the Company pursuant to which the Company’s stockholders own 

  
 less than fifty percent (50%) of the voting securities of the surviving entity or (ii) the sale of all
or substantially all of the assets of the Company. 
  
 (e) Warrant Shares. The term “Warrant
Shares” shall mean the Shares issuable or issued upon the exercise of this Warrant. 
  
 3. Method of
Exercise. While this Warrant remains outstanding and exercisable in accordance with Section 2 above, the holder may exercise at any time and from time to time during the Exercise Period, in whole or in part, the purchase rights evidenced hereby.
Such exercise shall be effected by: 
  
 (i) the surrender of this Warrant, together with a notice of exercise to the
Chief Financial Officer of the Company at its principal executive offices; and 
  
 (ii) the payment to the Company of
an amount equal to the aggregate Exercise Price for the number of Shares being purchased. 
  
 4. Certificates for
Shares. Upon the exercise of the purchase rights evidenced by this Warrant, one or more certificates for the number of Shares so purchased shall be issued as soon as practicable thereafter, and in any event within thirty (30) days of the
delivery of the notice of exercise. 
  
 5. Issuance of Shares; Reservation of Common Stock. The Company
covenants that the Shares, when issued pursuant to the exercise of this Warrant, will be duly and validly issued on the date the Warrant was exercised in accordance with Section 3 and will be fully paid and nonassessable and free from all taxes,
liens, and charges with respect to the issuance thereof. The Company further covenants that during the term this Warrant is exercisable, the Company will reserve from its authorized and unissued Common Stock a sufficient number of Shares to provide
for issuance of Common Stock upon the exercise of this Warrant and, from time to time, will take all steps necessary to amend its charter to provide sufficient reserves of Common Stock issuable upon exercise of this Warrant. 
  
 6. Adjustment of Exercise Price and Number of Shares. The number of and kind of securities purchasable upon exercise of this
Warrant and the Exercise Price shall be subject to adjustment from time to time as follows: 
  
 (a) Subdivisions,
Combinations and Other Issuances. If the Company shall at any time prior to the expiration of this Warrant subdivide its Shares, by split-up or otherwise, or combine its Shares, or issue additional shares of its Shares as a dividend, the number
of Shares issuable on the exercise of this Warrant shall forthwith be proportionately increased in the case of a subdivision or stock dividend, or proportionately decreased in the case of a combination. Appropriate adjustments shall also be made to
the purchase price payable per share, but the aggregate purchase price payable for the total number of Shares purchasable under this Warrant (as adjusted) shall remain the same. Any adjustment under this Section 6(a) shall become effective at the
close of business on the date 

 
 2 

  
 the subdivision or combination becomes effective, or as of the record date of such dividend, or in the
event that no record date is fixed, upon the making of such dividend. 
  
 (b) Reclassification, Reorganization and
Consolidation. In case of any reclassification, capital reorganization, or change in the capital stock of the Company (other than as a result of a subdivision, combination, or stock dividend provided for in Section 6(a) above or as a result of a
Change of Control), then the Company shall make appropriate provision so that the holder of this Warrant shall have the right at any time prior to the expiration of this Warrant to purchase, at a total price equal to that payable upon the exercise
of this Warrant, the kind and amount of shares of stock and other securities and property receivable in connection with such reclassification, reorganization, or change by a holder of the same number of Shares as were purchasable by the holder of
this Warrant immediately prior to such reclassification, reorganization, or change. In any such case appropriate provisions shall be made with respect to the rights and interest of the holder of this Warrant so that the provisions hereof shall
thereafter be applicable with respect to any shares of stock or other securities and property deliverable upon exercise hereof, and appropriate adjustments shall be made to the purchase price per share payable hereunder, provided the aggregate
purchase price shall remain the same. 
  
 (c) Notice of Adjustment. When any adjustment is required to be made
in the number or kind of shares purchasable upon exercise of the Warrant, or in the Exercise Price, the Company shall promptly notify the holder of such event and of any new Exercise Price or the number of Shares or the number and description of
other securities or property thereafter purchasable upon exercise of this Warrant. 
  
 7. Change of Control.
In case of any Change of Control, the Company shall make appropriate provision so that upon such Change of Control this Warrant shall automatically convert into a right to receive an amount of shares of stock and other securities and property
receivable by the Company’s securityholders in connection with such Change of Control (the “Consideration”) equal to the difference between: (a) the amount of Consideration receivable by a holder of the same number of Shares as were
purchasable by the holder of this Warrant immediately prior to such Change of Control minus (b) the amount of Consideration equal to the value of the cash consideration that would have been payable by the holder of this Warrant if this Warrant had
been fully exercised immediately prior to such Change of Control. 
  
 8. No Fractional Shares or Scrip. No
fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant, but in lieu of such fractional shares the Company shall make a cash payment therefor on the basis of the Exercise Price then in effect.

  
 9. Lost Warrant. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant and, in the case of any such loss, theft or destruction, upon delivery of an indemnity agreement reasonably satisfactory in form and amount to the Company or, in the case of any such mutilation, upon
surrender and cancellation of such Warrant, the Company, at the expense of the holder of this Warrant, shall execute and deliver to the holder of this Warrant, in lieu thereof, a new Warrant of like date and tenor. 

 
 3 

  
 10. Representations of the Company. The Company represents that all
corporate actions on the part of the Company, its officers, directors and stockholders necessary for the sale and issuance of this Warrant and the issuance of Shares on exercise of this Warrant have been taken. 
  
 11. Representations and Warranties by the Holder. The holder of this Warrant (the “Holder”) represents and warrants to
the Company as follows: 
  
 (a) This Warrant and the Shares issuable upon exercise thereof are being acquired for its
own account, for investment and not with a view to, or for resale in connection with, any distribution or public offering thereof within the meaning of the Securities Act of 1933, as amended (the “Act”). Upon exercise of this Warrant, the
Holder shall, if so requested by the Company, confirm in writing, in a form reasonably satisfactory to the Company, that the securities issuable upon exercise of this Warrant are being acquired for investment and not with a view toward distribution
or resale. 
  
 (b) The Holder understands that the Warrant and the Warrant Shares have not been registered under the
Act by reason of their issuance in a transaction exempt from the registration and prospectus delivery requirements of the Act pursuant to Section 4(2) thereof, and that they must be held by the Holder indefinitely, and that the Holder must therefore
bear the economic risk of such investment indefinitely, unless a subsequent disposition thereof is registered under the Act or is exempted from such registration. The Holder further understands that the Warrant and Warrant Shares have not been
qualified under the California Securities Law of 1968 (the “California Law”) by reason of their issuance in a transaction exempt from the qualification requirements of the California Law pursuant to Section 25102(f) thereof, which
exemption depends upon, among other things, the bona fide nature of the Holder’s investment intent expressed above. 
  
 (c) The Holder has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of the purchase of this Warrant and the Shares purchasable pursuant to the terms of this Warrant
and of protecting its interests in connection therewith. 
  
 (d) The Holder is able to bear the economic risk of the
purchase of the Shares issuable pursuant to the terms of this Warrant. 
  
 12. Restrictive Legend: The Warrant
Shares (unless registered under the Act) shall be stamped or imprinted with a legend in substantially the following form: 
  
 THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF, AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
SUCH SHARES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION UNLESS SUCH SALE OR TRANSFER IS EXEMPT FOR THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SAID ACT. 

 
 4 

  
 13. Transfer of Warrant. 
  
 (a) Conditions. This Warrant and the rights represented hereby are not transferable, except in accordance with the conditions set
forth in this Section 13. In order to affect any transfer of all or a portion of this Warrant, the Holder hereof shall deliver to the Company a completed and duly executed Notice of Transfer, in the form attached as Exhibit C hereto. 

 
 (b) Additional Conditions to Transfer of Warrant. Unless there is a registration statement declared or ordered effective
by the Securities and Exchange Commission under the Act which includes this Warrant, this Warrant may not be transferred unless and until: 
  
 (i) the Company receives an Investment Representation Statement, in the form attached as Exhibit B hereto, certifying that, among other things, this Warrant is being acquired for investment and not with a view to any
sale or distribution thereof; and 
  
 (ii) the Company receives a written notice from the Holder which describes the
manner and circumstances of the proposed transfer accompanied by (A) a written opinion of Holder’s legal counsel, in form and substance reasonably satisfactory to the Company, stating that such transfer is exempt from the registration and
prospectus delivery requirements of the Act and all applicable state securities laws, (B) a Commission “no-action” letter stating that future transfers of such securities by the transferor or the contemplated transferee would be exempt
from registration under the Act or such securities may be transferred in accordance with Rule 144(k) or (C) such other evidence that the proposed transfer is exempt from registration under the Act, in form and substance reasonably satisfactory to
the Company. Upon receipt of the foregoing, the Company shall, or shall instruct its transfer agent to, promptly, and without expense to the Holder or the Stockholder, as the case may be, issue new securities in the name of the Holder and/or the
Stockholder, as the case may be, not bearing the legends required under Section 12. In addition, new securities shall be issued without such legend if such legends may be properly removed under the terms of Rule 144(k). 
  
 14. Rights of Stockholders. No holder of this Warrant shall be entitled, as a Warrant holder, to vote or receive dividends or be
deemed the holder of the Shares or any other securities of the Company which may at any time be issuable on the exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon the holder of this Warrant, as such, any
of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action (whether upon any
recapitalization, issuance of stock, reclassification of stock, change of par value, consolidation, merger, conveyance, or otherwise) or to receive notice of meetings, or to receive dividends or subscription rights or otherwise until the Warrant
shall have been exercised and the Shares purchasable upon the exercise hereof shall have become deliverable, as provided herein. 
  
 15. Expiration of This Warrant. This Warrant shall expire and shall no longer be exercisable upon the fifth anniversary of the date hereof. 

 
 5 

  
 16. Notices. All notices, requests, demands, consents, instructions or
other communications required or permitted hereunder shall be in writing and faxed or delivered by courier to each party as follows: 
  
 if to the Investor, to; 
  
 CDC Software Corporation 
 c/o chinadotcom corporation 
 34/F Citicorp
Centre 
 18 Whitfield Road 
 Causeway Bay, Hong Kong, PRC 
 Tel: (852) 2893 8200 
 Fax: (852) 2893 5245 
 Attention: Company Secretary 
  
 with a copy to: 
  
 Torys LLP 
 237 Park Avenue 
 New York, NY 
 Tel: (212) 880-6106 
 Fax: (212) 682-0200 
 Attention: V. Carl
Walker, Esq. 
  
 or if to the Company, to; 
  
 Sagent Technology, Inc. 
 800 West El Camino
Real 
 Suite 300 
 Mountain
View, CA, 94040 
 Tel: (650) 815-3100 
 Fax: (650) 815-3500 
 Attention: Steven R. Springsteel 
  
 with a copy to: 
  
 Wilson Sonsini Goodrich & Rosati 
 650 Page Mill Road 
 Palo Alto, CA 94304 
 Tel: (650) 493-9300 
 Fax: (650) 493-6811 
 Attention: Kathleen B.
Bloch, Esq. 

 
 6 

  
 All such notices and communications shall be effective (a) when sent by Federal
Express or other overnight service of recognized standing, on the third business day following the deposit with such service; and (b) when faxed, upon confirmation of receipt. 
  
 17. Lock-up Agreement. The Holder hereby agrees that, upon request of the Company or the managing underwriter of a public offering of any securities of the Company,
such Holder shall not sell, make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of all or any portion of the Warrant Shares without the prior written consent of the Company or the managing underwriter, as the
case may be, for such period of time (not to exceed 180 days from the date upon which the registration statement relating to such public offering is declared or ordered effective by the Securities and Exchange Commission) as may be requested by the
Company or the underwriters, as the case may be. 
  
 18. Governing Law. This Warrant and all actions arising
out of or in connection with this Agreement shall be governed by and construed in accordance with the laws of the State of California, without regard to the conflicts of law provisions of the State of California or of any other jurisdiction. THE
PARTIES HERETO, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, EACH HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY AS TO ANY ISSUE RELATING HERETO IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT.

  
 19. Rights and Obligations Survive Exercise of Warrant. Unless otherwise provided herein, the rights and
obligations of the Company, of the holder of this Warrant and of the holder of the Shares issued upon exercise of this Warrant, shall survive the exercise of this Warrant. 
  
 [Remainder of page intentionally left blank.] 
  

 
 7 

  
 IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly
authorized officer as of the date first written above. 
  
 
	 SAGENT TECHNOLOGY, INC.
 a Delaware corporation

 
 
	 
	 By:
 	 	 

	  	 	  
	 

 
  
  
 Acknowledged and Accepted:

 
	  
	 
	 By:
 	 	 

	  	 	  
	 Name:
 	 	 

	  	 	  
	 Title:
 	 	 

	  	 	  
	 Address:
 	 	 

	  	 	  
	 

 
  

 EXHIBIT A 
  
 NOTICE OF EXERCISE 
  

	TO:
	 
	Sagent Technology, Inc. 
 

 800 W. El Camino
Real, Suite 300 
 Mountain View, California 94040 
 Attention: Chief Financial Officer 
  
 1. The undersigned hereby elects to purchase
             shares of Common Stock of Sagent Technology, Inc., a Delaware corporation (the “Company”), pursuant to the terms of Warrant No.
[            ], issued              , 2002 to and in the name of
[            ], a copy of which is attached hereto (the “Warrant”), and tenders herewith full payment of the aggregate Exercise Price for such shares in accordance with the terms
of the Warrant. 
  
 2. Please issue a certificate or certificates representing said shares of Common Stock in such
name or names as specified below: 
  
 
	 

	 (Name)
 	 	 (Name)
 
	  	 	  
	 

	  	 	  
	  	 	  
	 

	 (Address)
 	 	 (Address)
 

 
  
 3. The undersigned hereby represents and warrants that the
aforesaid shares of Common Stock are being acquired for the account of the undersigned for investment and not with a view to, or for resale in connection with, the distribution thereof, and that the undersigned has no present intention of
distributing or reselling such shares and all representations and warranties of the undersigned set forth in attached Warrant are true and correct as of the date hereof. In support thereof, the undersigned has executed an Investment Representation
Statement, in the form attached as Exhibit B to the Warrant, concurrently herewith. 
  
 
	  	 	  	 	  
	 
	 Date:
 	 	 
	 	  	 	 By:
 	 	 

	  	 	  	 	  	 	  	 	 (Signature)
 
	  	 	  	 	  	 	  	 	  
	  	 	  	 	  	 	  	 	 (Signature must conform in all respects to name of the Holder as set forth on the face of the Warrant)
 
	  	 	  	 	  	 	  	 	  
	  	 	  	 	  	 	  	 	  
	  	 	  	 	  	 	  	 	  
	  	 	  	 	  	 	  	 	  

 
  
  

	

  

  
 EXHIBIT B 
  
 INVESTMENT REPRESENTATION STATEMENT 
  
 
	 PURCHASER
 	  	 :
 	  	  
	  	  	  	  	  
	 SELLER
 	  	 :
 	  	 SAGENT TECHNOLOGY, INC.
 
	  	  	  	  	  
	 COMPANY
 	  	 :
 	  	 SAGENT TECHNOLOGY, INC
 
	  	  	  	  	  
	 SECURITY
 	  	 :
 	  	 WARRANT NO. [            ] ISSUED ON
            , 2002, OR COMMON STOCK ISSUED UPON THE EXERCISE OF WARRANT NO. [            ], ISSUED ON
                    
 
	  	  	  	  	  
	 AMOUNT
 	  	 :
 	  	                                 SHARES
 
	  	  	  	  	  
	 DATE
 	  	 :
 	  	 

	  	  	  	  	  

 
  
 The undersigned hereby represents and warrants to Sagent
Technology, Inc., a Delaware corporation (the “Company”), as follows: 
  
 1. I am aware of the business
affairs, financial condition and results of operations of the Company and have acquired sufficient information about the Company to reach an informed and knowledgeable investment decision to acquire the Securities. I am purchasing the Securities for
my own account for investment purposes only and not with a view to, or for the resale in connection with, any “distribution” thereof for purposes of the Securities Act of 1933, as amended (the “Securities Act”). 

 
 2. I understand that the Securities have not been registered under the Securities Act in reliance upon a specific exemption
therefrom, which exemption depends upon, among other things, the bona fide nature of my investment intent as expressed herein. I understand that, in the view of the Securities and Exchange Commission (the “Commission”), the statutory basis
for such exemption may be unavailable if my representation was predicated solely upon a present intention to hold the Securities for the minimum capital gains period specified under tax statutes, for a deferred sale, for or until an increase or
decrease in the market price of the Securities, or for a period of one year or any other fixed period in the future. 
  
 3. I further understand that the Securities must be held indefinitely unless subsequently registered under the Securities Act or unless an exemption from registration is otherwise available. Moreover, I understand that the Company is
under no obligation to register the Securities. In addition, I understand that the certificate evidencing the Securities shall be imprinted with a legend which prohibits the transfer of the Securities unless they are registered or such registration
is not required in the opinion of counsel satisfactory to the Company. 

  
 4. I am familiar with the provisions of Rule 144, promulgated under the
Securities Act, which, in substance, permits limited public resale of “restricted securities” acquired, directly or indirectly, from the issuer thereof, in a non-public offering subject to the satisfaction of certain conditions.

  
 5. I further understand that in the event all of the applicable requirements of Rule 144 are not satisfied,
registration under the Securities Act, compliance with Regulation A, or some other registration exemption shall be required; and that, notwithstanding the fact that Rule 144 is not exclusive, the Staff of the Commission has expressed its opinion
that persons proposing to sell private placement securities other than in a registered offering and otherwise than pursuant to Rule 144 shall have a substantial burden of proof in establishing that an exemption from registration is available for
such offers or sales, and that such persons and their respective brokers who participate in such transactions do so at their own risk. 
  
 
	  	 	  	 	  
	 
	 Date:
 	 	 
	 	  	 	 By:
 	 	 

	  	 	  	 	  	 	  	 	 (Signature must conform in all respects to name of the Holder as set forth on the face of the Warrant)
 

 
  
  

  
 EXHIBIT C 
  
 NOTICE OF TRANSFER 
  
 FOR VALUE
RECEIVED, the undersigned hereby sells, assigns and transfers unto              the right represented by Warrant No.
[            ], issued on              to and in the name of
[            ], to purchase shares of Common Stock of Sagent Technology, Inc., a Delaware corporation (the “Company”), a copy of which is attached hereto (the
“Warrant”), and
appoints                                        
as attorney-in-fact to transfer such right on the books of the Company with full power of substitution in the premises. 
  
 
	  	 	  	 	  
	 
	 Date:
 	 	 
	 	  	 	 By:
 	 	 

	  	 	  	 	  	 	  	 	 (Signature must conform in all respects to name of the Holder as set forth on the face of the Warrant)
 
	  	 	  	 	  	 	  	 	  
	  	 	  	 	  	 	  	 	 

	  	 	  	 	  	 	  	 	  
	  	 	  	 	  	 	  	 	 
(Address)
 
	  	 	  	 	  	 	  	 	  
	 Signed in the presence of:
 	 	  	 	  	 	  
	  	 	  	 	  	 	  	 	  
	 
	 	  	 	  	 	  
	 Name:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}]]